Serial Number
88976214
Owner
CELENIV PTE. LTD.Attorney
Camille M. MillerFirst Use Date
May 16, 2018
Filing Date
Jun 27, 2018
CC CELULARITY Trademark
Serial Number: 88976214 • Registration: 5957944
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Camille M. Miller COZEN O'CONNOR
1650 Market Street
Suite 2800
Philadelphia, PA 19103
United States
Trademark Details
Filing Date
June 27, 2018
Registration Date
January 7, 2020
First Use Anywhere
May 16, 2018
First Use in Commerce
May 16, 2018
Published for Opposition
October 30, 2018
Goods & Services
Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing written materials and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing
